GSK, Novartis agree to $4.5M penalty for misleading Osteo Gel claims
Competition & Consumer Protection 2020-05-04 3:40 pm By Alison Eveleigh | Sydney

Save(0) Please login to bookmark Username or Email Address Password Remember Me GlaxoSmithKline and Novartis have agreed to a combined penalty of $4.5 million after […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.